Monash Institute of Medical Research, Centre of Reproduction and Development, Monash University, Clayton, Victoria 3168, Australia.
Reproduction. 2011 Feb;141(2):183-91. doi: 10.1530/REP-10-0383. Epub 2010 Nov 12.
Cryopreservation of ovarian tissue is an important option for preserving the fertility of cancer patients undergoing chemotherapy and radiotherapy. In this study, we examined the viability and function of oocytes derived in vitro from pre-antral follicles as an alternative method for restoring fertility. Pre-antral follicles (specified as secondary follicle with a diameter around 100-130 μm) were mechanically isolated from vitrified-warmed and fresh adult mouse ovarian tissues and cultured for 12 days followed by an ovulation induction protocol at the end of this period to initiate oocyte maturation. Oocytes were then released from these follicles, fertilized in vitro, and cultured to the blastocyst stage and vitrified. After storage in liquid nitrogen for 2 weeks, groups of vitrified blastocysts were warmed and transferred into pseudo-pregnant recipient females. Although most of the isolated mouse pre-antral follicles from fresh (79.4%) and vitrified (75.0%) ovarian tissues survived the 12-day in vitro culture period, significantly fewer mature oocytes developed from vitrified-warmed pre-antral follicles than from the fresh controls (62.2 vs 86.4%, P<0.05). No difference was observed in embryo cleavage rates between these two groups, but the proportion of embryos that developed into blastocysts in the vitrification group was only half that of the controls (24.2 vs 47.2%, P<0.05). Nevertheless, live births of healthy normal pups were achieved after transfer of vitrified blastocysts derived from both experimental groups. This study shows that successful production of healthy offspring using an in vitro follicle culture system is feasible, and suggests that this procedure could be used in cancer patients who wish to preserve their fertility using ovarian tissue cryopreservation.
卵巢组织的冷冻保存是化疗和放疗的癌症患者保留生育能力的重要选择。在这项研究中,我们检查了从预腔前卵泡体外衍生的卵母细胞的活力和功能,作为恢复生育能力的替代方法。从冷冻解冻和新鲜成年小鼠卵巢组织中机械分离预腔前卵泡(指定为直径约 100-130μm 的次级卵泡),并培养 12 天,然后在这段时间结束时进行排卵诱导方案,以启动卵母细胞成熟。然后将这些卵泡中的卵母细胞释放出来,体外受精,并培养至囊胚阶段并冷冻。在液氮中储存 2 周后,将一组冷冻囊胚解冻并转移到假孕受体雌性体内。尽管来自新鲜(79.4%)和冷冻解冻(75.0%)卵巢组织的大多数分离的小鼠预腔前卵泡在 12 天的体外培养期内存活下来,但来自冷冻解冻预腔前卵泡的成熟卵母细胞数量明显少于新鲜对照组(62.2%对 86.4%,P<0.05)。这两组胚胎的卵裂率没有差异,但在冷冻组中发育成囊胚的胚胎比例仅为对照组的一半(24.2%对 47.2%,P<0.05)。然而,在转移来自两个实验组的冷冻囊胚后,成功生育了健康正常的幼崽。这项研究表明,使用体外卵泡培养系统成功生产健康后代是可行的,并表明该程序可用于希望使用卵巢组织冷冻保存保留生育能力的癌症患者。